Skip to main content
Caplight Logo









NovoThelium

NovoThelium

Private
San Antonio, TexasHealthcare & Life Scienceshttps://www.novothelium.com/

Last Round

Grant

Aug 16, 2018

Total Funding Raised

$202,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NovoThelium is a biotechnology company that develops a tissue-engineered matrix for nipple reconstruction after mastectomy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinetissue engineeringbreast reconstructionnipple reconstructiondecellularized scaffoldbiotechmedical deviceallograftextracellular matrixreconstructive surgerytissue scaffoldbiologicsbio-printing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NovoThelium Comparables

Compare NovoThelium with similar companies based on industry and business-model similarity.

NovoThelium comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BellaSeno
77%
GenesisTissue Inc.
77%
AbbVie
71%

NovoThelium Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 16, 2018
GrantJun 21, 2018
GrantMay 1, 2017
GrantMay 1, 2017

Key People

Founding team and executive leadership

Lauren Cornell

Co-Founder CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 120% MoM.

  • Jun 1, 2025

    Monthly visitors grew 232% MoM, from 94 to 312.

NovoThelium Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NovoThelium Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NovoThelium's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Antonio, Texas
Employee Range5
Year Founded2015
Last FundingAug 16, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?